Business
Researchers Identify a Potential Therapeutic Target for Multiple Sclerosis - Pharmacy Times
The findings show that inhibiting connexin 43 significantly improves multiple sclerosis symptoms in an experimental mouse model.
By: Pharmacytimes.com
- Aug 04 2024
- 0
- 0 Views
Inhibiting connexin 43 (Cx43) significantly improved symptoms for patients with chronic progressive multiple sclerosis (MS), according to researchers from Kyushu University in Japan. Their findings, … [+4048 chars]